BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 35159157)

  • 1. Mast Cell-Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth.
    Segura-Villalobos D; Ramírez-Moreno IG; Martínez-Aguilar M; Ibarra-Sánchez A; Muñoz-Bello JO; Anaya-Rubio I; Padilla A; Macías-Silva M; Lizano M; González-Espinosa C
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Mast Cell-Derived Adenosine in Cancer.
    Gorzalczany Y; Sagi-Eisenberg R
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of mast cell-derived hypoxia-inducible factor-1α in regulating mast cell function.
    Liang X; Yin G; Ma Y; Xu K; Liu J; Li J
    J Pharm Pharmacol; 2016 Nov; 68(11):1409-1416. PubMed ID: 27671226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis.
    Liu X; Li X; Wei H; Liu Y; Li N
    Front Immunol; 2023; 14():1209056. PubMed ID: 37497234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy.
    Sulsenti R; Jachetti E
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells: A double-edged sword in cancer.
    Derakhshani A; Vahidian F; Alihasanzadeh M; Mokhtarzadeh A; Lotfi Nezhad P; Baradaran B
    Immunol Lett; 2019 May; 209():28-35. PubMed ID: 30905824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.
    Johnson C; Huynh V; Hargrove L; Kennedy L; Graf-Eaton A; Owens J; Trzeciakowski JP; Hodges K; DeMorrow S; Han Y; Wong L; Alpini G; Francis H
    Am J Pathol; 2016 Jan; 186(1):123-33. PubMed ID: 26597881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers?
    Eissmann MF; Buchert M; Ernst M
    Front Immunol; 2020; 11():1389. PubMed ID: 32719677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
    Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F
    J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of mast cells in anticancer immunity.
    Dalton DK; Noelle RJ
    Cancer Immunol Immunother; 2012 Sep; 61(9):1511-20. PubMed ID: 22527244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells modulate proliferation, migration and stemness of glioma cells through downregulation of GSK3β expression and inhibition of STAT3 activation.
    Attarha S; Roy A; Westermark B; Tchougounova E
    Cell Signal; 2017 Sep; 37():81-92. PubMed ID: 28600192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversial role of mast cells in NSCLC tumor progression and angiogenesis.
    Longo V; Catino A; Montrone M; Galetta D; Ribatti D
    Thorac Cancer; 2022 Nov; 13(21):2929-2934. PubMed ID: 36196487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism.
    Jiménez-Andrade GY; Ibarra-Sánchez A; González D; Lamas M; González-Espinosa C
    J Hematol Oncol; 2013 Aug; 6():56. PubMed ID: 23915951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCF and IL-33 regulate mouse mast cell phenotypic and functional plasticity supporting a pro-inflammatory microenvironment.
    Molfetta R; Lecce M; Milito ND; Putro E; Pietropaolo G; Marangio C; Scarno G; Moretti M; De Smaele E; Santini T; Bernardini G; Sciumè G; Santoni A; Paolini R
    Cell Death Dis; 2023 Sep; 14(9):616. PubMed ID: 37730723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanomas and mast cells: an ambiguous relationship.
    Kohl LM; Sumpter TL
    Melanoma Res; 2024 Feb; 34(1):1-8. PubMed ID: 37924526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor.
    Gorzalczany Y; Akiva E; Klein O; Merimsky O; Sagi-Eisenberg R
    Cancer Lett; 2017 Jul; 397():23-32. PubMed ID: 28342985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses.
    Sumpter TL; Ho CH; Pleet AR; Tkacheva OA; Shufesky WJ; Rojas-Canales DM; Morelli AE; Larregina AT
    J Allergy Clin Immunol; 2015 Apr; 135(4):1019-1030.e8. PubMed ID: 25201259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focus on mast cells in the tumor microenvironment: Current knowledge and future directions.
    Shi S; Ye L; Yu X; Jin K; Wu W
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188845. PubMed ID: 36476563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-mast cell interactions: induction of pro-tumorigenic genes and anti-tumorigenic 4-1BB in MCs in response to Lewis Lung Carcinoma.
    Wensman H; Kamgari N; Johansson A; Grujic M; Calounova G; Lundequist A; Rönnberg E; Pejler G
    Mol Immunol; 2012 Apr; 50(4):210-9. PubMed ID: 22343053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers.
    Pittoni P; Tripodo C; Piconese S; Mauri G; Parenza M; Rigoni A; Sangaletti S; Colombo MP
    Cancer Res; 2011 Sep; 71(18):5987-97. PubMed ID: 21896641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.